Please provide your email address to receive an email when new articles are posted on . The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults ...
Please provide your email address to receive an email when new articles are posted on . Mean maximum ADAMTS13 activity after recombinant ADAMTS13 exceeded 100%. Markedly fewer patients receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results